CAR-T-cell therapy has revolutionized cancer treatment since its FDA approval in 2017, successfully engaging the immune system to combat advanced cancers. Physicians have noted astounding outcomes from the treatment, with patients who had exhausted all other options experiencing rapid tumor regression and life restoration. Dr. David Avigan and his colleagues highlight how patients once deemed terminal have reclaimed their health, emphasizing this therapy's potential to outperform previous treatments dramatically, thus providing renewed hope in oncology.
They had received every other known therapy and experimental therapy - nothing worked - and after CAR-T therapy they would go into remission and just a week later, be walking around like they were totally normal, even if they got really sick during the therapy.
But frankly, we've seen very dramatic responses in patients with advanced disease.
Collection
[
|
...
]